NCT01644734

Brief Summary

To evaluate the early (3-month) impact of the long-acting anticholinergic Spiriva HH maintenance treatment on the COPD symptoms using the novel COPD Assessment test (CAT) in the real life setting of COPD patients, previously treated with short-acting bronchodilator on regular or as-needed basis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,328

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Nov 2011

Geographic Reach
1 country

247 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

July 17, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 19, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

May 26, 2014

Completed
Last Updated

May 26, 2014

Status Verified

April 1, 2014

Enrollment Period

1.3 years

First QC Date

July 17, 2012

Results QC Date

March 28, 2014

Last Update Submit

April 30, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Patients Maintaining or Improving Their Health Status

    The health status was measured by the total COPD Assessment Test (CAT) score at baseline and at the end of the observation period after app. 3 months (visit 3). Therefore, the total CAT score at baseline and at Visit 3 was calculated by adding up the scores of the single questions of the CAT questionnaire. In the case of one or more missing items the total score was not determined for the specific visit. The health status is considered to be maintained or improved if the change in the total CAT score from baseline at Visit 3 is ≥0.

    Baseline, 3 months

Secondary Outcomes (1)

  • Change in the Total CAT Score (Value Baseline Minus 3 Months)

    Baseline, 3 months

Interventions

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female ambulatory outpatients being seen in a participating physicians office for routine care,
  • Patients with a clinical diagnosis of COPD (all stages according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2010) being treated with long-acting anticholinergic (Tiotropium, Spiriva® HandiHaler® ) as maintenance therapy within the product label and a maximum of the last 4 weeks (0.-28. days before Visit 1),
  • Patients previously treated with short-acting bronchodilators on regular or as-needed basis for at least 3 months before change to long-acting anticholinergic treatment,
  • Patient fluent in language of questionnaire and having the cognitive and functional abilities required to fill in the questionnaire alone.

You may not qualify if:

  • Uncooperative patients as judged by the physician,
  • Patients with any conditions excluded as per Country specific package insert,
  • Patients currently enrolled in any clinical trial,
  • Patients with COPD exacerbation or any acute disease in the last 3 months before Visit 1.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (247)

Boehringer Ingelheim Investigational Site 236

Andrychów, Poland

Location

Boehringer Ingelheim Investigational Site 170

Bialystok, Poland

Location

Boehringer Ingelheim Investigational Site 184

Bialystok, Poland

Location

Boehringer Ingelheim Investigational Site 240

Bialystok, Poland

Location

Boehringer Ingelheim Investigational Site 44

Bialystok, Poland

Location

Boehringer Ingelheim Investigational Site 84

Bialystok, Poland

Location

Boehringer Ingelheim Investigational Site 33

Bielsko-Biala, Poland

Location

Boehringer Ingelheim Investigational Site 34

Bielsko-Biala, Poland

Location

Boehringer Ingelheim Investigational Site 35

Bielsko-Biala, Poland

Location

Boehringer Ingelheim Investigational Site 79

Biskupiec, Poland

Location

Boehringer Ingelheim Investigational Site 116

Bochnia, Poland

Location

Boehringer Ingelheim Investigational Site 115

Brzesko, Poland

Location

Boehringer Ingelheim Investigational Site 138

Brzesko, Poland

Location

Boehringer Ingelheim Investigational Site 185

Brzeziny, Poland

Location

Boehringer Ingelheim Investigational Site 90

Brzozów, Poland

Location

Boehringer Ingelheim Investigational Site 105

Bydgoszcz, Poland

Location

Boehringer Ingelheim Investigational Site 119

Bydgoszcz, Poland

Location

Boehringer Ingelheim Investigational Site 123

Bydgoszcz, Poland

Location

Boehringer Ingelheim Investigational Site 222

Bydgoszcz, Poland

Location

Boehringer Ingelheim Investigational Site 27

Bydgoszcz, Poland

Location

Boehringer Ingelheim Investigational Site 21

Chełm, Poland

Location

Boehringer Ingelheim Investigational Site 22

Chełm, Poland

Location

Boehringer Ingelheim Investigational Site 11

Chełmsko Śląskie, Poland

Location

Boehringer Ingelheim Investigational Site 233

Chodzież, Poland

Location

Boehringer Ingelheim Investigational Site 226

Chojnice, Poland

Location

Boehringer Ingelheim Investigational Site 149

Chorzów, Poland

Location

Boehringer Ingelheim Investigational Site 153

Chorzów, Poland

Location

Boehringer Ingelheim Investigational Site 88

Ciechanów, Poland

Location

Boehringer Ingelheim Investigational Site 232

Czarnków, Poland

Location

Boehringer Ingelheim Investigational Site 229

Częstochowa, Poland

Location

Boehringer Ingelheim Investigational Site 4

Częstochowa, Poland

Location

Boehringer Ingelheim Investigational Site 23

Dąbrowa Górnicza, Poland

Location

Boehringer Ingelheim Investigational Site 92

Domaradz, Poland

Location

Boehringer Ingelheim Investigational Site 246

Dziergowice, Poland

Location

Boehringer Ingelheim Investigational Site 133

Gdansk, Poland

Location

Boehringer Ingelheim Investigational Site 134

Gdansk, Poland

Location

Boehringer Ingelheim Investigational Site 136

Gdansk, Poland

Location

Boehringer Ingelheim Investigational Site 155

Gdansk, Poland

Location

Boehringer Ingelheim Investigational Site 156

Gdansk, Poland

Location

Boehringer Ingelheim Investigational Site 20

Gdansk, Poland

Location

Boehringer Ingelheim Investigational Site 234

Gdansk, Poland

Location

Boehringer Ingelheim Investigational Site 31

Gdansk, Poland

Location

Boehringer Ingelheim Investigational Site 41

Gdynia, Poland

Location

Boehringer Ingelheim Investigational Site 217

Gliwice, Poland

Location

Boehringer Ingelheim Investigational Site 243

Gmina Jędrzejów, Poland

Location

Boehringer Ingelheim Investigational Site 141

Gmina Końskie, Poland

Location

Boehringer Ingelheim Investigational Site 142

Gmina Końskie, Poland

Location

Boehringer Ingelheim Investigational Site 73

Gmina Sawin, Poland

Location

Boehringer Ingelheim Investigational Site 107

Gmina Śrem, Poland

Location

Boehringer Ingelheim Investigational Site 213

Gmina Śrem, Poland

Location

Boehringer Ingelheim Investigational Site 181

Gmina Świecie, Poland

Location

Boehringer Ingelheim Investigational Site 38

Gmina Uchanie, Poland

Location

Boehringer Ingelheim Investigational Site 50

Gorzów Wielkopolski, Poland

Location

Boehringer Ingelheim Investigational Site 85

Góra, Poland

Location

Boehringer Ingelheim Investigational Site 174

Grodzisk Mazowiecki, Poland

Location

Boehringer Ingelheim Investigational Site 176

Grodzisk Mazowiecki, Poland

Location

Boehringer Ingelheim Investigational Site 56

Gryfice, Poland

Location

Boehringer Ingelheim Investigational Site 247

Głuchołazy, Poland

Location

Boehringer Ingelheim Investigational Site 179

Jarosław, Poland

Location

Boehringer Ingelheim Investigational Site 108

Jasło, Poland

Location

Boehringer Ingelheim Investigational Site 225

Jasło, Poland

Location

Boehringer Ingelheim Investigational Site 8

Jasło, Poland

Location

Boehringer Ingelheim Investigational Site 148

Jelenia Góra, Poland

Location

Boehringer Ingelheim Investigational Site 162

Katowice, Poland

Location

Boehringer Ingelheim Investigational Site 163

Katowice, Poland

Location

Boehringer Ingelheim Investigational Site 164

Katowice, Poland

Location

Boehringer Ingelheim Investigational Site 212

Katowice, Poland

Location

Boehringer Ingelheim Investigational Site 69

Kcynia, Poland

Location

Boehringer Ingelheim Investigational Site 112

Kielce, Poland

Location

Boehringer Ingelheim Investigational Site 18

Kielce, Poland

Location

Boehringer Ingelheim Investigational Site 19

Kielce, Poland

Location

Boehringer Ingelheim Investigational Site 219

Konin, Poland

Location

Boehringer Ingelheim Investigational Site 51

Koszalin, Poland

Location

Boehringer Ingelheim Investigational Site 52

Koszalin, Poland

Location

Boehringer Ingelheim Investigational Site 49

Kołobrzeg, Poland

Location

Boehringer Ingelheim Investigational Site 122

Krakow, Poland

Location

Boehringer Ingelheim Investigational Site 135

Krakow, Poland

Location

Boehringer Ingelheim Investigational Site 143

Krakow, Poland

Location

Boehringer Ingelheim Investigational Site 146

Krakow, Poland

Location

Boehringer Ingelheim Investigational Site 171

Krakow, Poland

Location

Boehringer Ingelheim Investigational Site 177

Krakow, Poland

Location

Boehringer Ingelheim Investigational Site 214

Krakow, Poland

Location

Boehringer Ingelheim Investigational Site 87

Krakow, Poland

Location

Boehringer Ingelheim Investigational Site 94

Krakow, Poland

Location

Boehringer Ingelheim Investigational Site 129

Kraśnik, Poland

Location

Boehringer Ingelheim Investigational Site 204

Kraśnik, Poland

Location

Boehringer Ingelheim Investigational Site 207

Kraśnik, Poland

Location

Boehringer Ingelheim Investigational Site 192

Krosno, Poland

Location

Boehringer Ingelheim Investigational Site 194

Kutno, Poland

Location

Boehringer Ingelheim Investigational Site 13

Kłodzko, Poland

Location

Boehringer Ingelheim Investigational Site 97

Legionowo, Poland

Location

Boehringer Ingelheim Investigational Site 86

Lędziny, Poland

Location

Boehringer Ingelheim Investigational Site 127

Liśnik Duży, Poland

Location

Boehringer Ingelheim Investigational Site 187

Lodz, Poland

Location

Boehringer Ingelheim Investigational Site 188

Lodz, Poland

Location

Boehringer Ingelheim Investigational Site 193

Lodz, Poland

Location

Boehringer Ingelheim Investigational Site 198

Lodz, Poland

Location

Boehringer Ingelheim Investigational Site 206

Lodz, Poland

Location

Boehringer Ingelheim Investigational Site 186

Lowicz, Poland

Location

Boehringer Ingelheim Investigational Site 158

Lubań, Poland

Location

Boehringer Ingelheim Investigational Site 37

Lubartów, Poland

Location

Boehringer Ingelheim Investigational Site 172

Lubin, Poland

Location

Boehringer Ingelheim Investigational Site 173

Lubin, Poland

Location

Boehringer Ingelheim Investigational Site 196

Lubin, Poland

Location

Boehringer Ingelheim Investigational Site 124

Lublin, Poland

Location

Boehringer Ingelheim Investigational Site 17

Lublin, Poland

Location

Boehringer Ingelheim Investigational Site 29

Lublin, Poland

Location

Boehringer Ingelheim Investigational Site 7

Lublin, Poland

Location

Boehringer Ingelheim Investigational Site 242

Lubliniec, Poland

Location

Boehringer Ingelheim Investigational Site 209

Luboń, Poland

Location

Boehringer Ingelheim Investigational Site 106

Ludwikowo, Poland

Location

Boehringer Ingelheim Investigational Site 45

Maków Mazowiecki, Poland

Location

Boehringer Ingelheim Investigational Site 168

Malbork, Poland

Location

Boehringer Ingelheim Investigational Site 110

Mielec, Poland

Location

Boehringer Ingelheim Investigational Site 159

Milicz, Poland

Location

Boehringer Ingelheim Investigational Site 25

Myszków, Poland

Location

Boehringer Ingelheim Investigational Site 150

Mysłowice, Poland

Location

Boehringer Ingelheim Investigational Site 215

Nisko, Poland

Location

Boehringer Ingelheim Investigational Site 128

Nowy Dwór Gdański, Poland

Location

Boehringer Ingelheim Investigational Site 109

Nowy Sącz, Poland

Location

Boehringer Ingelheim Investigational Site 72

Olecko, Poland

Location

Boehringer Ingelheim Investigational Site 36

Olsztyn, Poland

Location

Boehringer Ingelheim Investigational Site 245

Opatów, Poland

Location

Boehringer Ingelheim Investigational Site 114

Ostrowiec Świętokrzyski, Poland

Location

Boehringer Ingelheim Investigational Site 145

Ostrowiec Świętokrzyski, Poland

Location

Boehringer Ingelheim Investigational Site 154

Oława, Poland

Location

Boehringer Ingelheim Investigational Site 237

Pabianice, Poland

Location

Boehringer Ingelheim Investigational Site 182

Papowo Biskupie, Poland

Location

Boehringer Ingelheim Investigational Site 216

Pawonków, Poland

Location

Boehringer Ingelheim Investigational Site 189

Piekary Śląskie, Poland

Location

Boehringer Ingelheim Investigational Site 32

Pietrzykowice, Poland

Location

Boehringer Ingelheim Investigational Site 203

Piotrkow Trybunalski, Poland

Location

Boehringer Ingelheim Investigational Site 40

Piła, Poland

Location

Boehringer Ingelheim Investigational Site 93

Pniewy, Poland

Location

Boehringer Ingelheim Investigational Site 130

Poniatowa, Poland

Location

Boehringer Ingelheim Investigational Site 201

Poznan, Poland

Location

Boehringer Ingelheim Investigational Site 208

Poznan, Poland

Location

Boehringer Ingelheim Investigational Site 227

Poznan, Poland

Location

Boehringer Ingelheim Investigational Site 228

Poznan, Poland

Location

Boehringer Ingelheim Investigational Site 231

Poznan, Poland

Location

Boehringer Ingelheim Investigational Site 126

Prabuty, Poland

Location

Boehringer Ingelheim Investigational Site 218

Proszowice, Poland

Location

Boehringer Ingelheim Investigational Site 131

Pruszcz Gdański, Poland

Location

Boehringer Ingelheim Investigational Site 191

Przemyśl, Poland

Location

Boehringer Ingelheim Investigational Site 59

Płock, Poland

Location

Boehringer Ingelheim Investigational Site 169

Rabka-Zdrój, Poland

Location

Boehringer Ingelheim Investigational Site 117

Radom, Poland

Location

Boehringer Ingelheim Investigational Site 118

Radom, Poland

Location

Boehringer Ingelheim Investigational Site 151

Ruda Śląska, Poland

Location

Boehringer Ingelheim Investigational Site 152

Ruda Śląska, Poland

Location

Boehringer Ingelheim Investigational Site 230

Ruda Śląska, Poland

Location

Boehringer Ingelheim Investigational Site 82

Ruda Śląska, Poland

Location

Boehringer Ingelheim Investigational Site 180

Rumia, Poland

Location

Boehringer Ingelheim Investigational Site 239

Rumia, Poland

Location

Boehringer Ingelheim Investigational Site 5

Rumia, Poland

Location

Boehringer Ingelheim Investigational Site 104

Rybnik, Poland

Location

Boehringer Ingelheim Investigational Site 183

Rybnik, Poland

Location

Boehringer Ingelheim Investigational Site 83

Rybnik, Poland

Location

Boehringer Ingelheim Investigational Site 175

Rzeszów, Poland

Location

Boehringer Ingelheim Investigational Site 178

Rzeszów, Poland

Location

Boehringer Ingelheim Investigational Site 190

Sanok, Poland

Location

Boehringer Ingelheim Investigational Site 78

Sejny, Poland

Location

Boehringer Ingelheim Investigational Site 160

Siewierz, Poland

Location

Boehringer Ingelheim Investigational Site 241

Skarżysko-Kamienna, Poland

Location

Boehringer Ingelheim Investigational Site 157

Skawina, Poland

Location

Boehringer Ingelheim Investigational Site 10

Skoczów, Poland

Location

Boehringer Ingelheim Investigational Site 167

Skrzyszów, Poland

Location

Boehringer Ingelheim Investigational Site 14

Sokołowsko, Poland

Location

Boehringer Ingelheim Investigational Site 113

Sopot, Poland

Location

Boehringer Ingelheim Investigational Site 166

Sosnowiec, Poland

Location

Boehringer Ingelheim Investigational Site 24

Sosnowiec, Poland

Location

Boehringer Ingelheim Investigational Site 125

Stalowa Wola, Poland

Location

Boehringer Ingelheim Investigational Site 144

Starachowice, Poland

Location

Boehringer Ingelheim Investigational Site 80

Starachowice, Poland

Location

Boehringer Ingelheim Investigational Site 120

Stargard, Poland

Location

Boehringer Ingelheim Investigational Site 95

Sucha Beskidzka, Poland

Location

Boehringer Ingelheim Investigational Site 16

Supraśl, Poland

Location

Boehringer Ingelheim Investigational Site 54

Suwałki, Poland

Location

Boehringer Ingelheim Investigational Site 55

Suwałki, Poland

Location

Boehringer Ingelheim Investigational Site 76

Syców, Poland

Location

Boehringer Ingelheim Investigational Site 43

Szczecin, Poland

Location

Boehringer Ingelheim Investigational Site 48

Szczecin, Poland

Location

Boehringer Ingelheim Investigational Site 61

Szczecin, Poland

Location

Boehringer Ingelheim Investigational Site 66

Szczecin, Poland

Location

Boehringer Ingelheim Investigational Site 67

Szczecin, Poland

Location

Boehringer Ingelheim Investigational Site 26

Szczecinek, Poland

Location

Boehringer Ingelheim Investigational Site 53

Sławno, Poland

Location

Boehringer Ingelheim Investigational Site 96

Słubice, Poland

Location

Boehringer Ingelheim Investigational Site 205

Słupca, Poland

Location

Boehringer Ingelheim Investigational Site 1

Świdnik, Poland

Location

Boehringer Ingelheim Investigational Site 111

Tarnobrzeg, Poland

Location

Boehringer Ingelheim Investigational Site 224

Tarnobrzeg, Poland

Location

Boehringer Ingelheim Investigational Site 200

Tarnowskie Góry, Poland

Location

Boehringer Ingelheim Investigational Site 139

Tarnów, Poland

Location

Boehringer Ingelheim Investigational Site 140

Tarnów, Poland

Location

Boehringer Ingelheim Investigational Site 101

Torun, Poland

Location

Boehringer Ingelheim Investigational Site 70

Torun, Poland

Location

Boehringer Ingelheim Investigational Site 71

Torun, Poland

Location

Boehringer Ingelheim Investigational Site 220

Trzcianka Lubuska, Poland

Location

Boehringer Ingelheim Investigational Site 103

Twardogóra, Poland

Location

Boehringer Ingelheim Investigational Site 147

Tychy, Poland

Location

Boehringer Ingelheim Investigational Site 244

Tychy, Poland

Location

Boehringer Ingelheim Investigational Site 100

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 121

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 137

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 161

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 165

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 210

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 223

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 238

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 2

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 3

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 42

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 46

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 74

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 91

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 99

Warsaw, Poland

Location

Boehringer Ingelheim Investigational Site 39

Wałcz, Poland

Location

Boehringer Ingelheim Investigational Site 6

Wejherowo, Poland

Location

Boehringer Ingelheim Investigational Site 199

Wieliczna, Poland

Location

Boehringer Ingelheim Investigational Site 235

Wieluń, Poland

Location

Boehringer Ingelheim Investigational Site 197

Witonia, Poland

Location

Boehringer Ingelheim Investigational Site 65

Wloc³awek, Poland

Location

Boehringer Ingelheim Investigational Site 28

Wodzisław Śląski, Poland

Location

Boehringer Ingelheim Investigational Site 98

Wołomin, Poland

Location

Boehringer Ingelheim Investigational Site 102

Wroclaw, Poland

Location

Boehringer Ingelheim Investigational Site 202

Wroclaw, Poland

Location

Boehringer Ingelheim Investigational Site 221

Wroclaw, Poland

Location

Boehringer Ingelheim Investigational Site 62

Wroclaw, Poland

Location

Boehringer Ingelheim Investigational Site 63

Wroclaw, Poland

Location

Boehringer Ingelheim Investigational Site 64

Wroclaw, Poland

Location

Boehringer Ingelheim Investigational Site 89

Wroclaw, Poland

Location

Boehringer Ingelheim Investigational Site 68

Zabrze, Poland

Location

Boehringer Ingelheim Investigational Site 75

Zabrze, Poland

Location

Boehringer Ingelheim Investigational Site 77

Zabrze, Poland

Location

Boehringer Ingelheim Investigational Site 12

Ząbkowice Śląskie, Poland

Location

Boehringer Ingelheim Investigational Site 9

Ząbkowice Śląskie, Poland

Location

Boehringer Ingelheim Investigational Site 60

Zągoty, Poland

Location

Boehringer Ingelheim Investigational Site 132

Zblewo, Poland

Location

Boehringer Ingelheim Investigational Site 195

Zgierz, Poland

Location

Boehringer Ingelheim Investigational Site 15

Zielona Góra, Poland

Location

Boehringer Ingelheim Investigational Site 47

Zielona Góra, Poland

Location

Boehringer Ingelheim Investigational Site 81

Zielonka k/Warszawy, Poland

Location

Boehringer Ingelheim Investigational Site 211

Żyrardów, Poland

Location

Boehringer Ingelheim Investigational Site 57

Łomża, Poland

Location

Boehringer Ingelheim Investigational Site 58

Łomża, Poland

Location

Boehringer Ingelheim Investigational Site 30

Łuków, Poland

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Boehringer Ingelheim Call Center
Organization
Boehringer Ingelheim Pharmaceuticals

Study Officials

  • Boehringer Ingelheim

    Boehringer Ingelheim

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2012

First Posted

July 19, 2012

Study Start

November 1, 2011

Primary Completion

March 1, 2013

Study Completion

March 1, 2013

Last Updated

May 26, 2014

Results First Posted

May 26, 2014

Record last verified: 2014-04

Locations